Stay updated on Pembrolizumab & Sunitinib in Thymic Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab & Sunitinib in Thymic Cancer Clinical Trial page.

Latest updates to the Pembrolizumab & Sunitinib in Thymic Cancer Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe page revision was updated from v3.6.5 to v3.6.6, indicating a newer version of the study entry. This appears to be an internal revision with no changes to the study details or visible content.SummaryDifference0.1%

- Check24 days agoNo Change Detected
- Check38 days agoChange DetectedStudy Record Dates were updated with several entries changing from Estimated to Actual, and the revision tag was updated to Revision: v3.6.5, indicating a new version of the study record.SummaryDifference0.4%

- Check52 days agoChange DetectedThe page shows a revision update from v3.6.3 to v3.6.4, indicating a software update to the site's tooling. It appears to affect only versioning metadata, not the study details.SummaryDifference0.1%

- Check74 days agoChange DetectedThe page revision tag was updated from v3.6.2 to v3.6.3, indicating a maintenance update. No visible study details or functionality appear to be altered.SummaryDifference0.1%

- Check81 days agoChange DetectedThe page revision label was updated from v3.6.0 to v3.6.2, indicating a small update to the page software or documentation. No study content or user-facing information was altered.SummaryDifference0.1%

- Check95 days agoChange DetectedAdded new navigation/help sections—How to Read a Study Record, Common Questions, and How to Join a Study—and a recruitment note stating No longer looking for participants. The Intervention / Treatment heading was normalized to Intervention/Treatment and the page revision stamp updated to v3.6.0.SummaryDifference0.4%

Stay in the know with updates to Pembrolizumab & Sunitinib in Thymic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Sunitinib in Thymic Cancer Clinical Trial page.